Literature DB >> 27449501

The Feasibility of Using Metacognitive Strategy Training to Improve Cognitive Performance and Neural Connectivity in Women with Chemotherapy-Induced Cognitive Impairment.

Timothy J Wolf1, Meghan Doherty, Dorina Kallogjeri, Rebecca S Coalson, Joyce Nicklaus, Cynthia X Ma, Bradley L Schlaggar, Jay Piccirillo.   

Abstract

OBJECTIVE: To evaluate the feasibility and preliminary effect of metacognitive strategy training (MCST) on cognitive performance and on neural connectivity in the frontoparietal network in women with chemotherapy-induced cognitive impairment (CICI) following treatment for breast cancer.
METHODS: A single-group pre/post study was conducted. After completing the baseline assessment battery and neuroimaging, the participants completed a 12-session MCST intervention. Following the completion of the intervention, the subjects completed the same assessment battery and neuroimaging as was completed at baseline within 4 weeks after the intervention. The key inclusion/exclusion criteria for this study were: completed chemotherapy for treatment of breast cancer, no other neurological or psychiatric diagnoses, self-reported CICI, and no contraindications to the use of MRI.
RESULTS: MCST had a small-to-large positive effect on all primary (cognitive) and secondary (quality of life and psychosocial) behavioral outcome measures (r = -0.12 to -0.88). There was also a positive change in functional connectivity in a frontoparietal cognitive control network connection in 6 of the 10 subjects, which was correlated to changes in the behavioral measures.
CONCLUSIONS: This study found that MCST was associated with a positive effect on cognitive performance and neural connectivity in women with CICI following treatment for breast cancer.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27449501      PMCID: PMC5016221          DOI: 10.1159/000447744

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  51 in total

1.  Frequencies contributing to functional connectivity in the cerebral cortex in "resting-state" data.

Authors:  D Cordes; V M Haughton; K Arfanakis; J D Carew; P A Turski; C H Moritz; M A Quigley; M E Meyerand
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

2.  Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population.

Authors:  Inger Schou; Øivind Ekeberg; Leif Sandvik; Marianne J Hjermstad; Cornelia M Ruland
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

3.  Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.

Authors:  K K Kwong; J W Belliveau; D A Chesler; I E Goldberg; R M Weisskoff; B P Poncelet; D N Kennedy; B E Hoppel; M S Cohen; R Turner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

5.  Effect size estimates: current use, calculations, and interpretation.

Authors:  Catherine O Fritz; Peter E Morris; Jennifer J Richler
Journal:  J Exp Psychol Gen       Date:  2011-08-08

6.  Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts.

Authors:  J G Ojemann; E Akbudak; A Z Snyder; R C McKinstry; M E Raichle; T E Conturo
Journal:  Neuroimage       Date:  1997-10       Impact factor: 6.556

7.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

8.  Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging.

Authors:  S Ogawa; D W Tank; R Menon; J M Ellermann; S G Kim; H Merkle; K Ugurbil
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

9.  Cognitive impairment after chemotherapy related to atypical network architecture for executive control.

Authors:  Jay F Piccirillo; Frances Mei Hardin; Joyce Nicklaus; Dorina Kallogjeri; Michael Wilson; Cynthia X Ma; Rebecca S Coalson; Joshua Shimony; Bradley L Schlaggar
Journal:  Oncology       Date:  2015-02-07       Impact factor: 2.935

Review 10.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  4 in total

1.  Cognitive Training for Adults With Bothersome Tinnitus: A Randomized Clinical Trial.

Authors:  Dorina Kallogjeri; Jay F Piccirillo; Edward Spitznagel; Sandra Hale; Joyce E Nicklaus; Frances Mei Hardin; Joshua S Shimony; Rebecca S Coalson; Bradley L Schlaggar
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-05-01       Impact factor: 6.223

Review 2.  Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction.

Authors:  Brenna C McDonald
Journal:  Neurotherapeutics       Date:  2021-08-16       Impact factor: 7.620

3.  Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox.

Authors:  Parul Sinha; Alex W K Wong; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

4.  The role of metamemory on cognitive complaints in cancer patients.

Authors:  Bénédicte Giffard; Audrey Perrotin; Philippe Allain; Jacques Dayan; Francis Eustache; Jean-Michel Grellard; Audrey Faveyrial; Florence Joly; Marie Lange
Journal:  Brain Behav       Date:  2020-03-10       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.